The Rapid COVID-19 Antigen Test is an in vitro-immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab from individuals who are suspected of COVID-19 by their healthcare provider. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
The novel coronaviruses belong to theβgenus. COVID-19 is an acute respiratory infectious disease. Currently, individuals infected by SARS-CoV-2 are the main source of transmission; asymptomatic carriers are also known as a source of transmission. Based on the current epidemiological information, the incubation period can last from 1 to 14 days, where the average time before symptoms occur in about 5 days. Symptoms include fever or chills, cough, shortness of breath, fatigue, muscle or body aches, headache, the new loss of taste or smell, sore throat, runny nose, nausea or vomiting, and diarrhea.
Qualitative, visually read results in 15 minutes
No instrument required
Room temperature storage or refrigerated (2-30⁰C / 36-86⁰F)
Procedural internal control included
Sterile Swabs, Extraction Buffer and Extraction Tubes included
Positive Percent Agreement (PPA): 95.7%
Negative Percent Agreement (NPA): 99.6%
Overall Percent Agreement (OPA): 98.9%
Specimen: Nasopharyngeal (NP) Swab
Time to Results: 15 minutes
Shelf Life: 24 months from the date of manufacture